Last reviewed · How we verify
NCT03883061
Mathematical Modeling and Risk Factor Analysis for Mortality of Sepsis
trial testing regular medical treatment in Morality in 2,000 participants. Status unknown.
1 March 2019
Quick facts
| Lead sponsor | Shanghai Tongji Hospital, Tongji University School of Medicine |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 2,000 |
| Start date | 1 January 2017 |
| Primary completion | 1 March 2019 |
| Estimated completion | 31 December 2021 |
| Sites | 1 location across China |
Drugs / interventions tested
- regular medical treatment
Conditions studied
- Morality — all drugs for Morality →
- Risk Factor, Sepsis — all drugs for Risk Factor, Sepsis →
- Predictive Model — all drugs for Predictive Model →
Sponsor
Shanghai Tongji Hospital, Tongji University School of Medicine
Who can join
Adults 14 to 99, any sex, with Morality or Risk Factor, Sepsis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study was to investigate the risk factors for mortality of sepsis and to create mathematical models to predict the survival rate based on electronic health records that extracted from hospital information system. More than 1000 records should be collected and used to data analysis. Univariate and multivariable logistic regression model were applied to risk factors analysis for the outcome, and machine learn algorithms were employed to generate predictive models for the outcome.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03883061
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of regular medical treatment
Trials testing the same drug.
- NCT03274908 — Real-world Clinical Study and Medical Machine Intelligence Study for Traditional Chinese Internal Medicine · unknown
Other recruiting trials for Morality
Currently open trials in the same condition.
- NCT07187596 — Mortality Outcome of Controlled Hypertension · active not recruiting
- NCT07009847 — An Observational Study to Assess Effectiveness and Safety of The R21/Matrix-M Malaria Vaccine · recruiting
- NCT06570759 — Time for a Diagnostic Paradigm Shift From STEMI/NSTEMI to OMI/NOMI · NA · active not recruiting
- NCT06452966 — The Impact and Effect of Traditional Chinese Medicine Treatment on Organ Failure in Critically Ill Patients · NA · recruiting
- NCT06420479 — The Causal Effect of Bariatric Surgery on Cardiovascular Disease and Mortality · recruiting
Other Shanghai Tongji Hospital, Tongji University School of Medicine trials
Trials by the same sponsor.
- NCT07384390 — TH-CAR-027 for Grade 4 Gliomas · EARLY_PHASE1 · not yet recruiting
- NCT07043218 — A Clinical Study Exploring Universal CAR-T Cell in Patients With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia · Phase 1 · not yet recruiting
- NCT07064109 — Multi-omics Characterization and Model Construction of Colchicine Anti-inflammatory Therapy Efficacy in ACS Patients · NA · recruiting
- NCT06951425 — An Exploratory Clinical Study of the Efficiency and Safety of TH027 in the Treatment of Relapsed/Refractory Solid Tumors · EARLY_PHASE1 · not yet recruiting
- NCT06987916 — Efficacy and Safety Evaluation of U01(ssCART-19) in B-Cell Lymphoma · Phase 1, PHASE2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03883061 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Shanghai Tongji Hospital, Tongji University School of Medicine
- Last refreshed: 6 January 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03883061.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing